Caroline H. Williams‐Gray

17.4k total citations · 6 hit papers
113 papers, 10.2k citations indexed

About

Caroline H. Williams‐Gray is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Caroline H. Williams‐Gray has authored 113 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Neurology, 31 papers in Physiology and 27 papers in Cellular and Molecular Neuroscience. Recurrent topics in Caroline H. Williams‐Gray's work include Parkinson's Disease Mechanisms and Treatments (88 papers), Neurological disorders and treatments (32 papers) and Neuroinflammation and Neurodegeneration Mechanisms (20 papers). Caroline H. Williams‐Gray is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (88 papers), Neurological disorders and treatments (32 papers) and Neuroinflammation and Neurodegeneration Mechanisms (20 papers). Caroline H. Williams‐Gray collaborates with scholars based in United Kingdom, Australia and United States. Caroline H. Williams‐Gray's co-authors include Roger A. Barker, Thomas Foltynie, Trevor W. Robbins, Carol Brayne, Jonathan Evans, David J. Burn, Sarah Mason, Daniel Weintraub, Dag Aarsland and Jaime Kulisevsky and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Neuroscience.

In The Last Decade

Caroline H. Williams‐Gray

109 papers receiving 10.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

2012 1.9k citations Ben Schmand, Caroline H. Williams‐Gray et al. Movement Disorders profile →
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

2009 736 citations Caroline H. Williams‐Gray, Jonathan Evans et al. Brain profile →
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort

2007 729 citations Caroline H. Williams‐Gray, Thomas Foltynie et al. Brain profile →
Mild cognitive impairment in Parkinson disease

2010 569 citations Caroline H. Williams‐Gray, David J. Burn et al. Neurology profile →
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

2013 469 citations Caroline H. Williams‐Gray, Sarah Mason et al. Journal of Neurology Neurosurgery & Psychiatry profile →
The pathogenesis of Parkinson's disease

2024 419 citations Huw R. Morris, Maria Grazia Spillantini et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline H. Williams‐Gray United Kingdom	45	7.4k	2.4k	2.1k	2.0k	1.8k	113	10.2k
Murat Emre Türkiye	47	7.1k 1.0×	2.4k 1.0×	2.2k 1.0×	3.2k 1.6×	1.9k 1.1×	164	11.9k
Jaime Kulisevsky Spain	55	9.4k 1.3×	3.9k 1.6×	1.5k 0.7×	3.3k 1.6×	2.8k 1.5×	321	13.8k
Brit Mollenhauer Germany	59	9.0k 1.2×	2.2k 0.9×	3.9k 1.8×	2.6k 1.3×	1.9k 1.0×	206	13.6k
Ubaldo Bonuccelli Italy	56	6.6k 0.9×	1.7k 0.7×	1.5k 0.7×	2.1k 1.0×	2.5k 1.4×	365	11.1k
Nicolaas I. Bohnen United States	57	5.3k 0.7×	2.2k 0.9×	1.7k 0.8×	2.3k 1.2×	2.3k 1.3×	189	10.4k
Howard I. Hurtig United States	63	9.5k 1.3×	2.5k 1.0×	3.6k 1.7×	2.4k 1.2×	3.0k 1.6×	140	13.9k
Piu Chan China	51	7.6k 1.0×	2.2k 0.9×	2.5k 1.2×	1.1k 0.6×	2.7k 1.5×	189	13.5k
Kenneth Marek United States	52	9.9k 1.3×	1.8k 0.8×	2.0k 0.9×	1.2k 0.6×	3.5k 1.9×	189	13.5k
María Rodríguez‐Oroz Spain	54	10.8k 1.4×	3.1k 1.3×	1.2k 0.6×	1.5k 0.8×	5.1k 2.8×	147	13.8k
Matthew Stern United States	33	8.3k 1.1×	1.4k 0.6×	1.2k 0.6×	1.2k 0.6×	2.2k 1.2×	68	10.3k

Countries citing papers authored by Caroline H. Williams‐Gray

Since Specialization

Citations

This map shows the geographic impact of Caroline H. Williams‐Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline H. Williams‐Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline H. Williams‐Gray more than expected).

Fields of papers citing papers by Caroline H. Williams‐Gray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline H. Williams‐Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline H. Williams‐Gray. The network helps show where Caroline H. Williams‐Gray may publish in the future.

Co-authorship network of co-authors of Caroline H. Williams‐Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline H. Williams‐Gray. A scholar is included among the top collaborators of Caroline H. Williams‐Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline H. Williams‐Gray. Caroline H. Williams‐Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Kirsten M., Lennart R. B. Spindler, Alexander R. D. Peattie, et al.. (2025). Multimodal markers of immune activation predict cognitive outcomes in Parkinson’s disease. Brain Behavior and Immunity. 129. 165–178. 1 indexed citations

Greenland, Julia C., Jonathan Holbrook, Marta Camacho, et al.. (2025). Peripheral-central immune crosstalk in Parkinson’s disease and its association with clinical severity. Brain Behavior and Immunity. 128. 558–570. 3 indexed citations

Wu, Hao, Junhao Wang, Jean‐Christophe Corvol, et al.. (2025). Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease. Movement Disorders. 40(9). 1908–1918.

Zhang, Yu P., et al.. (2024). Improved Imaging Surface for Quantitative Single-Molecule Microscopy. ACS Applied Materials & Interfaces. 16(28). 37255–37264. 3 indexed citations

Roodveldt, Cintia, Liliana Bernardino, Özgür Öztop Çakmak, et al.. (2024). The immune system in Parkinson's disease: what we know so far. Brain. 147(10). 3306–3324. 41 indexed citations

Morris, Huw R., Maria Grazia Spillantini, Carolyn M. Sue, & Caroline H. Williams‐Gray. (2024). The pathogenesis of Parkinson's disease. The Lancet. 403(10423). 293–304. 419 indexed citations breakdown →

Hezemans, Frank H., Rong Ye, Alexander G. Murley, et al.. (2024). Noradrenergic modulation of saccades in Parkinson’s disease. Brain Communications. 6(5). fcae297–fcae297. 1 indexed citations

Brown, Guy C., Marta Camacho, & Caroline H. Williams‐Gray. (2023). The Endotoxin Hypothesis of Parkinson's Disease. Movement Disorders. 38(7). 1143–1155. 42 indexed citations

Ye, Rong, Frank H. Hezemans, Claire O’Callaghan, et al.. (2023). Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy. Journal of Neuroscience. 43(42). 7028–7040. 7 indexed citations

10.

Emin, Derya, Yu P. Zhang, Evgeniia Lobanova, et al.. (2022). Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease. Nature Communications. 13(1). 5512–5512. 121 indexed citations

11.

Hezemans, Frank H., Noham Wolpe, Claire O’Callaghan, et al.. (2022). Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes. PLoS Computational Biology. 18(5). e1010079–e1010079. 29 indexed citations

12.

O’Callaghan, Claire, Frank H. Hezemans, Rong Ye, et al.. (2021). Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease. Brain. 144(8). 2513–2526. 59 indexed citations

13.

Wijeyekoon, Ruwani, Deborah Kronenberg‐Versteeg, Kirsten M. Scott, et al.. (2020). Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease. Brain Behavior and Immunity. 87. 473–488. 72 indexed citations

14.

Jensen, Melanie P., Kirsten M. Scott, Marta Camacho, et al.. (2019). 123 T and B lymphocyte senescence in parkinson’s disease. Journal of Neurology Neurosurgery & Psychiatry. 90(12). e35.1–e35. 1 indexed citations

15.

Williams‐Gray, Caroline H. & Roger A. Barker. (2017). Defining PD subtypes — a step toward personalized management?. Nature Reviews Neurology. 13(8). 454–455. 8 indexed citations

16.

Velseboer, Daan C., Rob M.A. de Bie, Luuk Wieske, et al.. (2016). Development and external validation of a prognostic model in newly diagnosed Parkinson disease. Neurology. 86(11). 986–993. 38 indexed citations

17.

Lawson, Rachael A., Alison J. Yarnall, Gordon W. Duncan, et al.. (2016). Cognitive decline and quality of life in incident Parkinson's disease: The role of attention. Parkinsonism & Related Disorders. 27. 47–53. 149 indexed citations

18.

Williams‐Gray, Caroline H., Sarah Mason, Jonathan Evans, et al.. (2013). The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. Journal of Neurology Neurosurgery & Psychiatry. 84(11). 1258–1264. 469 indexed citations breakdown →

19.

Goris, An, Caroline H. Williams‐Gray, Graeme R. Clark, et al.. (2007). Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease. Annals of Neurology. 62(2). 145–153. 224 indexed citations

20.

Williams‐Gray, Caroline H., Thomas Foltynie, Simon J.G. Lewis, & Roger A. Barker. (2006). Cognitive Deficits and Psychosis in Parkinson???s Disease. CNS Drugs. 20(6). 477–505. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact